Status:
COMPLETED
Transferrin Saturation and Asthenia in Hemochromatosis
Lead Sponsor:
Rennes University Hospital
Conditions:
Hemochromatoses, Genetic
Eligibility:
All Genders
18+ years
Brief Summary
Observational study.
Detailed Description
The linked HFE genetic hemochromatosis (C282Y mutation in the homozygous state) is the most common form of genetic iron overload. Its treatment is based on bloodletting, and takes place in 2 phases, ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- homozygous C282Y ;
- in the maintenance phase for at least 6 months ;
- follow-up at Rennes University Hospital ;
- patient who has not expressed his opposition to participate in the study.
- Exclusion criteria:
- Permanent: any cause of modification of the CST unrelated to hemochromatosis (chronic inflammatory disease, excessive consumption of alcohol ...) ;
- Temporary: infectious syndrome within 7 days before bleeding.
Exclusion
Key Trial Info
Start Date :
April 10 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 9 2019
Estimated Enrollment :
260 Patients enrolled
Trial Details
Trial ID
NCT03356548
Start Date
April 10 2017
End Date
April 9 2019
Last Update
July 31 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rennes University Hospital
Rennes, Britain, France, 35033